MAPT and Alzheimer disease: Conversely, a decrease in the abundance of anti-inflammatory SCFAs, due to reduced levels of Butyrivibrio and Eubacterium, exacerbates chronic neuroinflammation, elevates APP and tau expression levels, and contributes to AD pathogenesis [45].